TY  - JOUR
AU  - Riestra, Sabino
AU  - Taxonera, Carlos
AU  - Zabana, Yamile
AU  - Carpio, Daniel
AU  - Chaparro, Maria
AU  - Barrio, Jesus
AU  - Rivero, Montserrat
AU  - Lopez-Sanroman, Antonio
AU  - Esteve, Maria
AU  - de Francisco, Ruth
AU  - Bastida, Guillermo
AU  - Garcia-Lopez, Santiago
AU  - Mañosa, Miriam
AU  - Martin-Arranz, Maria Dolores
AU  - Perez-Calle, Jose Lazaro
AU  - Guardiola, Jordi
AU  - Muñoz, Fernando
AU  - Arranz, Laura
AU  - Cabriada, Jose Luis
AU  - Garcia-Sepulcre, Mariana Fe
AU  - Navarro, Merce
AU  - Montoro-Huguet, Miguel Angel
AU  - Ricart, Elena
AU  - Bermejo, Fernando
AU  - Calvet, Xavier
AU  - Piqueras, Marta
AU  - Garcia-Planella, Esther
AU  - Marquez, Lucia
AU  - Minguez, Miguel
AU  - Van-Domselar, Manuel
AU  - Bujanda, Luis
AU  - Aldeguer, Xavier
AU  - Sicilia, Beatriz
AU  - Iglesias, Eva
AU  - Alcain, Guillermo
AU  - Perez-Martinez, Isabel
AU  - Rolle, Valeria
AU  - Castaño-Garcia, Andres
AU  - P Gisbert, Javier
AU  - Domenech, Eugeni
PY  - 2022
DO  - 10.3390/jcm11133915
SN  - 2077-0383
UR  - http://hdl.handle.net/10668/21318
T2  - Journal of clinical medicine
AB  - (1) Aims: Patients receiving antitumor necrosis factor (anti-TNF) therapy are at risk of developing tuberculosis (TB), usually due to the reactivation of a latent TB infection (LTBI). LTBI screening and treatment decreases the risk of TB. This study...
LA  - en
PB  - MDPI
KW  - Inflammatory bowel disease
KW  - Interferon gamma release assays
KW  - Latent tuberculosis infection
KW  - Tuberculin skin test
KW  - Interferon-gamma release tests
KW  - Tuberculin test
KW  - Tumor necrosis factor inhibitors
KW  - Latent tuberculosis
KW  - Immunologic factors
KW  - Inflammatory bowel diseases
KW  - Probability
KW  - Necrosis
TI  - Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU.
TY  - Research article
VL  - 11
ER  -